Lv11
20 积分 2025-02-18 加入
Sacituzumab tirumotecan in previously treated metastatic triple-negative breast cancer: a randomized phase 3 trial
59分钟前
已完结
Sacituzumab Tirumotecan Across Gynecologic Malignancies: One Target, Multiple Diseases
1小时前
已完结
基于TCGA数据库的宫颈癌免疫基因预后模型构建及预后标志物鉴定
1个月前
已完结
Reactive Hypoglycaemia at Glucose Tolerance Test-Another Presentation of Gestational Diabetes: A Multicentre Retrospective Study
6个月前
已完结
基于TCGA数据库的宫颈癌免疫基因预后模型构建及预后标志物鉴定
6个月前
已完结
Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial
7个月前
已完结
Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial
7个月前
已完结
Pembrolizumab plus chemotherapy for advanced and recurrent cervical cancer: final analysis according to bevacizumab use in the randomized KEYNOTE-826 study
7个月前
已完结
Multimodal CT and MRI Radiomics Integrated with Clinical Models Predict Pathological Complete Response in ESCC Following Neoadjuvant Immunochemotherapy
7个月前
已完结
皖公网安备34019202002308
